Stock Analysis
- Australia
- /
- Healthtech
- /
- ASX:ALC
Alcidion Group And 2 Other ASX Penny Stocks To Consider
Reviewed by Simply Wall St
The Australian stock market has experienced a slight downturn, with the ASX200 down 1% and sectors like Discretionary and Financials showing notable declines. Despite these challenges, penny stocks remain an intriguing area of investment, often representing smaller or emerging companies that can offer significant value. By focusing on those with strong financial foundations, investors may uncover opportunities for growth amidst the volatility.
Top 10 Penny Stocks In Australia
Name | Share Price | Market Cap | Financial Health Rating |
Embark Early Education (ASX:EVO) | A$0.77 | A$139.45M | ★★★★☆☆ |
LaserBond (ASX:LBL) | A$0.55 | A$64.47M | ★★★★★★ |
MaxiPARTS (ASX:MXI) | A$1.80 | A$99.02M | ★★★★★★ |
SHAPE Australia (ASX:SHA) | A$2.85 | A$235.47M | ★★★★★★ |
Helloworld Travel (ASX:HLO) | A$1.885 | A$312.61M | ★★★★★★ |
Austin Engineering (ASX:ANG) | A$0.49 | A$306.97M | ★★★★★☆ |
Navigator Global Investments (ASX:NGI) | A$1.59 | A$771.88M | ★★★★★☆ |
EZZ Life Science Holdings (ASX:EZZ) | A$2.91 | A$134.78M | ★★★★★★ |
SKS Technologies Group (ASX:SKS) | A$1.59 | A$190.52M | ★★★★★★ |
Vita Life Sciences (ASX:VLS) | A$1.80 | A$99.85M | ★★★★★★ |
Click here to see the full list of 1,052 stocks from our ASX Penny Stocks screener.
Let's explore several standout options from the results in the screener.
Alcidion Group (ASX:ALC)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Alcidion Group Limited develops and licenses healthcare software products in Australia, New Zealand, and the United Kingdom, with a market cap of A$80.58 million.
Operations: The company's revenue primarily comes from the provision of healthcare software solutions, amounting to A$37.06 million.
Market Cap: A$80.58M
Alcidion Group, with a market cap of A$80.58 million, operates in the healthcare software sector across Australia, New Zealand, and the UK. Despite being unprofitable and having increased losses over five years at a rate of 27.5% per year, Alcidion is debt-free and trading at a significant discount to its estimated fair value. The company has sufficient cash runway for over a year based on current free cash flow but faces challenges with short-term liabilities exceeding short-term assets by A$0.7M. Analyst consensus suggests potential stock price growth of 38.9%. Recent executive changes aim for seamless operational continuity.
- Dive into the specifics of Alcidion Group here with our thorough balance sheet health report.
- Gain insights into Alcidion Group's future direction by reviewing our growth report.
Aims Property Securities Fund (ASX:APW)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Aims Property Securities Fund, with a market cap of A$76.13 million, is a close-ended fund of funds launched by MacArthurCook Ltd.
Operations: The fund's revenue segments include contributions from AIMS APAC REIT (A$0.56 million), AIMS Total Return Fund (A$0.62 million), AIMS Property Fund (Laverton) (A$36.12 million), and AIMS Real Estate Opportunity Fund (A$1.21 million).
Market Cap: A$76.13M
Aims Property Securities Fund, with a market cap of A$76.13 million, demonstrates strong financial health through its debt-free status and high-quality earnings. The fund's net profit margins have improved to 94.6% from last year's 90.6%, and its earnings growth rate over the past year (61.1%) significantly surpasses both its five-year average (32.4% per year) and the REITs industry growth rate of 3.1%. With no long-term liabilities, short-term assets covering liabilities, and a seasoned board averaging 14.3 years in tenure, the fund is positioned well despite a low return on equity of 14.5%.
- Navigate through the intricacies of Aims Property Securities Fund with our comprehensive balance sheet health report here.
- Learn about Aims Property Securities Fund's historical performance here.
Rand Mining (ASX:RND)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Rand Mining Limited is involved in the exploration, development, and production of mineral properties in Australia with a market cap of A$88.73 million.
Operations: The company generates revenue from its Metals & Mining segment, focusing on Gold & Other Precious Metals, amounting to A$34.76 million.
Market Cap: A$88.73M
Rand Mining Limited, with a market cap of A$88.73 million, operates debt-free and has stable weekly volatility of 7%. Despite trading at 71.7% below its estimated fair value, the company faces challenges with declining earnings over the past five years at an annual rate of 18.2% and negative growth in the last year. The seasoned management team averages 21.9 years in tenure, supporting high-quality earnings despite a low return on equity of 6.8%. Recent events include a fully franked dividend declaration of A$0.10 per share for fiscal year ending June 2024, indicating shareholder returns amidst financial pressures.
- Click here and access our complete financial health analysis report to understand the dynamics of Rand Mining.
- Gain insights into Rand Mining's past trends and performance with our report on the company's historical track record.
Key Takeaways
- Embark on your investment journey to our 1,052 ASX Penny Stocks selection here.
- Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
- Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.
Want To Explore Some Alternatives?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Jump on the AI train with fast growing tech companies forging a new era of innovation.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ASX:ALC
Alcidion Group
Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.